Company Profile
Sensei Biotherapeutics Stock Price, News & Analysis
- Ticker:
- SNSE
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
13.85 USD (+6.54%)
Close
Last updated: June 15, 2026
21.6M USD
Market cap
Why the stock is moving
Current closing-price context is not available for SNSE.
Company overview
Business overview
Sensei Biotherapeutics is an immuno-oncology company focused on activating the immune system against cancer. Its platform aims to create differentiated cancer treatments through immune modulation.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Sensei sits in specialty oncology biotechnology.
Business Model Characteristics
The company depends on clinical data, immune-mechanism validation, and the ability to build a durable cancer franchise.
Position Within the Biotechnology Landscape
Sensei is a catalyst-driven immuno-oncology name whose stock responds to early clinical and translational progress.
Future catalysts
The cleaner way to frame Sensei Biotherapeutics right now is around its latest development priorities. The most useful line from the latest update is First patient dosed in Phase 1b/2 trial of PIKTOR in HR+/HER2- advanced breast cancer Topline Phase 2 data in patients with advanced endometrial cancer expected in second half.... That should keep the program at the center of the company narrative for now.
Recent news
- 01
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Source: Sensei Biotherapeutics
- 02
Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
Source: Sensei Biotherapeutics
- 03
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Source: Sensei Biotherapeutics
- 04
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
Source: Sensei Biotherapeutics
- 05
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Sensei Biotherapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sensei Biotherapeutics (SNSE)?
Sensei Biotherapeutics (SNSE) most recently closed at 13.85 USD, a +6.54% move versus the previous session.
What is the market cap of Sensei Biotherapeutics (SNSE)?
Sensei Biotherapeutics currently has a market capitalization of 21.6M USD on BioPharmSignal.
What does Sensei Biotherapeutics do?
Sensei Biotherapeutics is an immuno-oncology company focused on activating the immune system against cancer. Its platform aims to create differentiated cancer treatments through immune modulation.
On which exchange is SNSE stock listed?
Sensei Biotherapeutics (SNSE) is associated with NYSE, United States, Biopharma.
What is Sensei?
The cleaner way to frame Sensei Biotherapeutics right now is around its latest development priorities.
Which conditions is Sensei Biotherapeutics targeting with Sensei?
Sensei Biotherapeutics is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Sensei Biotherapeutics describe recent progress with Sensei?
The cleaner way to frame Sensei Biotherapeutics right now is around its latest development priorities.
What is Biotherapeutics?
Sensei Biotherapeutics is an immuno-oncology company focused on activating the immune system against cancer.